Skip to Primary Navigation

Pharma conference digs into Gilead case, executive orders, CMS audits

PCC 2025 conference panel featuring Sara Kimball (Daiichi Sankyo); Margaret Feltz (Purdue) and Nikki Reeves (King & Spalding)
PCC 2025 conference panel featuring Sara Kimball (Daiichi Sankyo); Margaret Feltz (Purdue) and Nikki Reeves (King & Spalding). Photo: Julie DiMauro

At the annual pharmaceutical compliance event, speakers discussed the Gilead False Claims Case and Trump administration initiatives.

At the spring 2025 Pharmaceutical Compliance Congress (PCC) event in McLean, Virginia, speakers had many best practice tips and lessons learned to share with attendees, but they also pointed to several recent settlement actions, executive orders and state-led initiatives that were setting the tone for healthcare regulation in 2025 and